A free radical scavenger, edaravone, prevents ischemia-reperfusion injury in liver grafts from non-heart-beating donors.

[1]  T. Rikiyama,et al.  A new free radical scavenger, edaravone, ameliorates oxidative liver damage due to ischemia-reperfusion in vitro and in vivo , 2004, Journal of Gastrointestinal Surgery.

[2]  K. Olthoff,et al.  Survival Following Liver Transplantation From Non-Heart-Beating Donors , 2004, Annals of surgery.

[3]  A. Wakatsuki,et al.  Edaravone protects against ischemia/reperfusion-induced oxidative damage to mitochondria in rat liver. , 2003, European journal of pharmacology.

[4]  K. Sugimachi,et al.  Beneficial effect of MCI-186 on hepatic warm ischemia-reperfusion in the rat. , 2002, Transplantation.

[5]  K. Messmer,et al.  MICROCIRCULATORY FAILURE AFTER RAT LIVER TRANSPLANTATION IS RELATED TO KUPFFER CELL-DERIVED OXIDANT STRESS BUT NOT INVOLVED IN EARLY GRAFT DYSFUNCTION1 , 2001, Transplantation.

[6]  N. Ohkohchi,et al.  Assessment of viability of the liver graft in different cardiac arrest models. , 2000, Transplantation proceedings.

[7]  N. Ohkohchi,et al.  Fragility of the electron transport chain and superoxide generation in mitochondria of the liver graft after cold ischemia. , 1999, Transplantation.

[8]  T. Watanabe,et al.  Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. , 1994, The Journal of pharmacology and experimental therapeutics.

[9]  L. Toledo-Pereyra,et al.  INFLUENCE OF OXYGEN‐DERIVED FREE RADICAL SCAVENGERS ON ISCHEMIC LIVERS , 1985, Transplantation.

[10]  H. Jaeschke,et al.  Reactive oxygen and ischemia/reperfusion injury of the liver. , 1991, Chemico-biological interactions.